Prasanta Raghab Mohapatra

12PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyMedical mycologyChemotherapyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 22, 2025
The Rs 100 "R+Cu" (resveratrol and copper) anti-cancer magic tablet controversy: Results of online survey among oncologists.

Purvish M Parikh, Narayanan Prasad, Raja Thirumalairaj

|Sep 03, 2025
Agreement between the one-minute sit-to-stand test and the six-minute walk test in assessing exercise capacity in patients with interstitial lung disease.

Akshaya Moorthy, Prasanta Raghab Mohapatra, Sourin Bhuniya

|May 22, 2023
Letter in Response to "Melioidosis in a Tertiary Care Center from South India: A 5-year Experience.

Bijayini Behera, Srujana Mohanty, Baijayantimala Mishra

|Dec 20, 2022
Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.

M C Arjun, Arvind Kumar Singh, Debkumar Pal

|Sep 26, 2022
A Delphi consensus statement for the management of post-COVID interstitial lung disease.

Vijay Hadda, Tejas M Suri, Hariharan Iyer

Pageof 2